FOLD FY 2009 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

FY 2009 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$64M+330.0% YoY

Gross Profit

$64M100.0% margin

Operating Income

-$7M-11.4% margin

Net Income

-$7M-10.2% margin

EPS (Diluted)

$-0.29

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$45M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$85M

Total Liabilities

$14M

Stockholders' Equity

$72M

Cash & Equivalents

$19M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$15M	+330.0%
Gross Profit	$64M	$15M	+330.0%
Operating Income	-$7M	-$44M	+83.3%
Net Income	-$7M	-$39M	+83.3%